PFA
IBB icon

Paradigm Financial Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Paradigm Financial Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$644K Sell
4,220
-482
-10% -$74.6K 0.14% 101
2021
Q3 		$760K Buy
4,702
+435
+10% +$73.2K 0.18% 95
2021
Q2 		$698K Sell
4,267
-965
-18% -$149K 0.16% 101
2021
Q1 		$788K Sell
5,232
-3,313
-39% -$526K 0.19% 92
2020
Q4 		$1.29M Sell
8,545
-1,833
-18% -$262K 0.35% 60
2020
Q3 		$1.41M Sell
10,378
-4,167
-29% -$565K 0.4% 50
2020
Q2 		$1.99M Buy
14,545
+107
+0.7% +$13.6K 0.63% 44
2020
Q1 		$1.56M Sell
14,438
-346
-2% -$39.8K 0.58% 49
2019
Q4 		$1.78M Sell
14,784
-4,208
-22% -$469K 0.61% 48
2019
Q3 		$1.89M Sell
18,992
-4,138
-18% -$433K 0.74% 41
2019
Q2 		$2.52M Sell
23,130
-843
-4% -$89.7K 0.93% 38
2019
Q1 		$2.68M Buy
23,973
+157
+0.7% +$17.2K 1.02% 35
2018
Q4 		$2.3M Sell
23,816
-867
-4% -$92K 1.02% 33
2018
Q3 		$3.01M Buy
24,683
+331
+1% +$39K 1.18% 30
2018
Q2 		$2.67M Sell
24,352
-1,246
-5% -$133K 1.14% 30
2018
Q1 		$2.73M Buy
25,598
+2,009
+9% +$223K 1.19% 28
2017
Q4 		$2.52M Buy
23,589
+720
+3% +$77K 1.14% 30
2017
Q3 		$2.54M Buy
22,869
+924
+4% +$98.8K 1.23% 30
2017
Q2 		$2.27M Buy
21,945
+2,298
+12% +$226K 1.15% 30
2017
Q1 		$1.92M Buy
19,647
+2,478
+14% +$237K 0.98% 33
2016
Q4 		$1.52M Buy
+17,169
New +$1.56M 0.83% 35
2014
Q2 		– Sell
-300
Closed -$24K – 130
2014
Q1 		$24K Hold
300
– – 0.02% 160
2013
Q4 		$23K Buy
+300
New +$21.3K 0.02% 182

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Paradigm Financial Advisors's IBB Position: Q4 2021 in Review

Paradigm Financial Advisors reduced its iShares Biotechnology ETF (IBB) stake by 10% in Q4 2021, selling an estimated $74.6K and leaving 4,220 shares worth $644K. The position accounts for 0.14% of the portfolio, ranked #101.

Paradigm Financial Advisors first reported a position in IBB in Q4 2013 and has held it in 23 quarters since. The position peaked at $3.01M in Q3 2018. 962 funds tracked by Wall St. Rank hold IBB as of Q4 2021.

  • Paradigm Financial Advisors held 4,220 shares of iShares Biotechnology ETF worth $644K as of Q4 2021.
  • Paradigm Financial Advisors sold 482 iShares Biotechnology ETF shares in Q4 2021, an estimated $74.6K.
  • iShares Biotechnology ETF made up 0.14% of Paradigm Financial Advisors's portfolio in Q4 2021, its #101 holding.
  • Paradigm Financial Advisors first reported a position in iShares Biotechnology ETF in Q4 2013 and has held it in 23 quarters since.
  • Paradigm Financial Advisors's iShares Biotechnology ETF position peaked at $3.01M in Q3 2018.
  • 962 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2021.

Based on Paradigm Financial Advisors's 13F filing for Q4 2021, filed 10 Feb 2022.